The Chemours Company (NYSE:CC) Shares Sold by Folger Nolan Fleming Douglas Capital Management Inc.

Folger Nolan Fleming Douglas Capital Management Inc. cut its stake in shares of The Chemours Company (NYSE:CC) by 5.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 679,826 shares of the specialty chemicals company’s stock after selling 41,736 shares during the quarter. Chemours accounts for approximately 2.3% of Folger Nolan Fleming Douglas Capital Management Inc.’s holdings, making the stock its 7th biggest position. Folger Nolan Fleming Douglas Capital Management Inc. owned approximately 0.46% of Chemours worth $21,442,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of CC. Bank of New York Mellon Corp lifted its holdings in Chemours by 11.0% in the third quarter. Bank of New York Mellon Corp now owns 6,196,063 shares of the specialty chemicals company’s stock valued at $173,800,000 after acquiring an additional 612,071 shares during the period. Massachusetts Financial Services Co. MA lifted its holdings in Chemours by 10.0% in the third quarter. Massachusetts Financial Services Co. MA now owns 3,160,740 shares of the specialty chemicals company’s stock valued at $88,659,000 after acquiring an additional 286,076 shares during the period. Deutsche Bank AG lifted its holdings in Chemours by 4,407.9% in the third quarter. Deutsche Bank AG now owns 1,759,419 shares of the specialty chemicals company’s stock valued at $49,352,000 after acquiring an additional 1,720,389 shares during the period. American Century Companies Inc. lifted its holdings in Chemours by 0.7% in the third quarter. American Century Companies Inc. now owns 1,459,463 shares of the specialty chemicals company’s stock valued at $40,938,000 after acquiring an additional 10,075 shares during the period. Finally, Vaughan Nelson Investment Management L.P. lifted its holdings in Chemours by 2.2% in the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 1,381,801 shares of the specialty chemicals company’s stock valued at $43,582,000 after acquiring an additional 29,475 shares during the period. 76.26% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CC has been the subject of a number of recent analyst reports. Barclays reduced their target price on Chemours from $32.00 to $30.00 and set an “equal weight” rating for the company in a report on Tuesday, April 2nd. BMO Capital Markets raised Chemours from an “underperform” rating to an “outperform” rating and lifted their price target for the stock from $19.00 to $34.00 in a research note on Tuesday, April 9th. Finally, UBS Group lifted their price target on Chemours from $21.00 to $28.00 and gave the stock a “neutral” rating in a research note on Tuesday, April 2nd. Seven analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Chemours has an average rating of “Hold” and an average target price of $30.89.

Chemours Stock Performance

Shares of NYSE:CC traded up $0.29 during midday trading on Friday, hitting $27.32. 776,635 shares of the stock were exchanged, compared to its average volume of 1,222,749. The company has a 50 day moving average price of $26.72 and a 200-day moving average price of $27.79. The Chemours Company has a twelve month low of $15.10 and a twelve month high of $39.05. The company has a current ratio of 1.54, a quick ratio of 1.00 and a debt-to-equity ratio of 5.40.

Chemours (NYSE:CC) last posted its quarterly earnings data on Wednesday, March 27th. The specialty chemicals company reported $0.31 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.02. The firm had revenue of $1.36 billion during the quarter, compared to analysts’ expectations of $1.37 billion. Chemours had a positive return on equity of 51.73% and a negative net margin of 3.80%. As a group, equities analysts expect that The Chemours Company will post 2.23 EPS for the current fiscal year.

Chemours Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Monday, February 26th were given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 3.66%. The ex-dividend date of this dividend was Friday, February 23rd. Chemours’s dividend payout ratio is presently -64.52%.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.